Gene Query: GINM1

Dataset Description Geneva Score
Gene expression changes after LOC550643 silencing 84.48
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 27.48
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 16.06
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 16.06
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 15.94
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 15.69
miR941 overexpression experiment 15.5
SUV420H2 knockdown in PANC-1 15.38
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 14.73
Regulation of Lipids is Central to Replicative Senescence 14.04
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 13.9
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 13.9
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 13.58
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 13.11
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 12.96
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 12.96
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 12.89
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 12.89
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 12.37
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 12.25
Cleavage Factor Im as a key regulator of 3’ UTR length 12.04
miRNAs affected by antagomiR-17 treatment 11.9
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 11.56
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer [RNA-seq] 11.28
A Novel PI3K Regulator, ARID4B, Presents Synthetic Essentiality in PTEN-deficient Prostate Cancer 11.28
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 10.52
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 10.16
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 9.87
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 9.84
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 9.54
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 9.44
KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors 9.35
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 9.19
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 9.14
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 8.82
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 8.82
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 8.77
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 8.73
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 8.73
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 8.69
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 8.59
A549 cells and MSR-A549 cells 8.59
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 8.45
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 8.37
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 8.35
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 8.35
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 7.77
Expression profiling of etoposide-induced senescent cells 7.69
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 7.56
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 7.54
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 7.44
Effect of mitochondria deficiency on senescence-associated gene expression 7.38
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 7.27
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 7.23
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 7.17
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 7.07
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 7.01
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 6.93
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 6.93
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 6.91
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 6.87
RNA editing in nascent RNA affects pre-mRNA splicing 6.83
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 6.8
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 6.74
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 6.74
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 6.64
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 6.63
Transcriptome analysis of SKI knock-out in HL60 cells 6.61
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 6.61
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 6.44
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 6.43
Differential gene expression of human melanoma cells [RNA-seq] 6.43
Ultracentifugation and nanoscale deterministic lateral displacement (nanoDLD) of samples for exRNA analysis 6.37
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 6.35
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 6.35
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 6.35
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 6.29
IRF2 is a master regulator of human keratinocyte stem cell fate 6.29
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 6.27
Biological effect of chronic mistranslation in mammalian cells 6.26
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 6.14
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 6.14
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 6.12
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 6.01
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 5.99
Genome-wide chromatin analysis of Ewing sarcoma 5.96
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 5.96
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 5.91
Endothelial gene expression analysis 5.91
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 5.82
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 5.82
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 5.79
SLIGRL-induced gene expression changes in NHEK cells 5.75
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 5.65
GATA3-mediated chromatin reprogramming in breast cancer cells 5.62
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 5.59
Expression level comparison under dividing and quiescent states in human primary fibroblasts 5.58
Next Generation Sequencing Facilitates Quantitative Analysis of Human Primary and Pluripotent Stem Cell-Derived Epicardial Cell Transcriptomes 5.57
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 5.54
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 5.54
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 5.52
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 5.51
High-Throughput Kinetic Analysis of Fractional Killing 5.49
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 5.48
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 5.38
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 5.38
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 5.37
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 5.33
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 5.29
Region-specific Innate Antiviral Responses of the Human Epididymis 5.27
LNCaP treated with iBET 5.14
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 5.12
RNA-seq analysis to identify the genes regulated by p53-SET interplay 5.1
The evolution of N6-methyladenosine in primates 5.09
Genome wide expression change in LCC2 and MCF-7 cells 5.08
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 5.07
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 5.07
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 5.05
Chromatin-informed inference of transcriptional programs in gynecologic cancers 5.05
A transcriptome-wide divergence in protein translation scales with LIN28B expression 5.03
Small-molecule targeting of brachyury transcription factor addiction in chordoma 5.01
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 4.96
High-efficiency RNA-based reprogramming of human primary fibroblasts 4.96
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 4.9
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 4.9
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 4.9
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 4.89
Controlling for gene expression changes in transcription factor protein networks. 4.89
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 4.88
ARID1A and ARID1B loss in HCT116 and TOV21G cells 4.88
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 4.87
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 4.85
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 4.85
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 4.83
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 4.82
DNA Methylation Reprograms Metabolic Gene Expression in End-Stage Human Heart Failure 4.76
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 4.74
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 4.74
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 4.72
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 4.69
Gene expression profiling of KSHV-infected periodontal ligament cells 4.69
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 4.68
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 4.68
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 4.68
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 4.63
Transcriptome analysis of kidney organoids 4.6
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 4.56
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 4.56
Transciptomic profiling of human fetal lung samples 4.48
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 4.46
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 4.44
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 4.43
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 4.42
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 4.42
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 4.42
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 4.41
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 4.37
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 4.33
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 4.32
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 4.3
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 4.28
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 4.25
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 4.24
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 4.24
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 4.22
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 4.21
Mapping interactions for the TNIP2 hub protein 4.18
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 4.18
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 4.17
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 4.17
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 4.16
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 4.14
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 4.11
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 4.1
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 4.1
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 4.09
RNA-seq of MCF10A cells and CAF 4.07
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 4.07
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 4.06
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 4.06
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 4.04
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 4.04
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 4.04
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 4.03
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 4.02
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 4.0
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 3.99
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 3.99
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 3.95
Altering cancer transcriptomes using epigenomic inhibitors 3.95
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 3.95
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 3.94
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 3.94
Non-coding regions are the main source of tumor-specific antigens [human] 3.94
Non-coding regions are the main source of tumor-specific antigens 3.94
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 3.92
RNA-seq of human fibroblasts after irradiation 3.91
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 3.89
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 3.89
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 3.86
mRNA-Seq profiling of human developing kidney 3.85
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 3.83
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 3.83
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 3.82
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 3.79
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 3.79
RNA-Seq to assess the transcriptional effects of G quadruplex stabilization by the G4 ligand PhenDC3 in HT-1080 cells 3.78
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 3.77
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 3.73
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 3.71
Global Mapping of Human RNA-RNA Interactions 3.7
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 3.7
Landscape and variation of RNA secondary structure across the human transcriptome 3.7
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 3.62
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 3.62
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 3.62
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 3.61
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 3.61
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 3.55
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 3.52
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 3.51
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 3.5
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 3.5
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 3.5
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 3.47
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 3.47
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 3.42
Effect of FGF13 depletion on the H460 cell line 3.4
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 3.39
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 3.39
Identification of renal resident macrophages across species 3.38
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 3.37
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 3.36
PGE2 mediated gene expression changes in human cervical stromal cells 3.36
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 3.34
Transcriptome of diurnal human blood neutrophils 3.33
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 3.3
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 3.29
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 3.29
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 3.28
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 3.25
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 3.24
Gene expression profiling of human iPS cell-derived podocytes and sorted human adult podocytes 3.24
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 3.24
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 3.22
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 3.22
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.21
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.21
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 3.21
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 3.2
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 3.18
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 3.18
Effect of from Human Umbilical Vein Endothelial Cells 3.17
Widespread intronic polyadenylation diversifies immune cell transcriptomes 3.11
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 3.11
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 3.09
Epithelial-mesenchymal transition markers screenedina cell-based model and validated in lung adenocarcinoma 3.09
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 3.06
MRTF activates TEAD-YAP target gene expression 3.06
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 3.06
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 3.0
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 2.99
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 2.97
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 2.96
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 2.96
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 2.93
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 2.93
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 2.93
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 2.89
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 2.89
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 2.88
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 2.86
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.86
UBC9 knockdown in bladder cancer T24 cell lines 2.84
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 2.82
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 2.82
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 2.81
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 2.81
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 2.8
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 2.79
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 2.78
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 2.77
Downregulation of LATS kinases alters p53 to promote cell migration 2.76
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 2.76
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 2.74
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.72
RNA-seq differential expression studies: more sequence, or more replication? 2.71
The Genetic Landscape of Diamond-Blackfan Anemia 2.7
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.63
miR-93 Targets in Human Endothelial Cells 2.61
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 2.6
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.59
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 2.59
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 2.59
Transcriptional changes in lymphoma cells induced by LSD1 depletion 2.59
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 2.58
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 2.57
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 2.57
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 2.55
RNA-seq analysis of the human fetal kidney. 2.52
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 2.51
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 2.51
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 2.45
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 2.44
Gene expression in GBM with Cav3.2 inhibition 2.4
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 2.4
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 2.38
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 2.36
KSDM1b Role in Ewing Sarcoma 2.34
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 2.32
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 2.29
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 2.28
Identification of a Cell-of-Origin for Fibroblasts Comprising the Fibrotic Reticulum in Idiopathic Pulmonary Fibrosis 2.27
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.25
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.25
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 2.22
Ribosomal protein RPL26 is the principal target of UFMylation 2.2
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 2.16
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 2.16
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 2.15
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 2.15
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 2.15
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 2.15
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 2.15
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp1] 2.13
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 2.12
Redifferentiation of expanded human islet β cells by inhibition of ARX 2.09
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.07
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 2.04
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 2.03
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 2.03
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 1.98
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.97
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.97
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 1.97
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 1.97
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.95
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 1.91
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 1.86
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 1.86
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.83
Transcriptomic profile of human embryonic renal corpuscles 1.75
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence 1.73
ATRX is necessary for cellular senescence and represses HRAS to drive cells from quiescence into senescence [RNA-Seq] 1.73
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 1.73
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 1.66
LIN28A modulates splicing and gene expression programs in breast cancer cells 1.66
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 1.65
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 1.64
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 1.63
Cell responses to dysregulated VZV-induced cell-cell fusion 1.59
Genome-wide analysis of the Integrator complex (HTS) 1.59
Genome-wide analysis of the Integrator complex 1.59
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 1.57
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 1.55
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 1.52
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 1.51
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 1.51
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 1.49
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.49
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 1.47
Single-cell analysis of human kidney organoids 1.45
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 1.42
Expression profiling of MCF-7 cells with treatment of TCDD 1.42
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 1.42
FOXP1 orchestration of ASD-relevant signaling pathways. 1.41
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 1.4
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 1.39
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 1.38
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 1.38
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 1.36
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 1.33
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.33
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.31
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 1.31
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 1.28
Gene expression profiling of papillary thyroid cancer from central and invasive regions 1.25
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.23
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 1.22
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 1.22
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 1.21
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 1.21
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 1.21
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.2
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.19
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.19
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 1.17
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.15
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 1.14
SNHG5 siRNA knock down in HCT116 cells 1.13
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 1.11
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 1.1
Interaction between mitoNEET and NAF-1 in cancer cells 1.09
Identification of differentially expressed genes between senescence and senescence bypass cells 1.08
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 1.05
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 1.04
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 1.04
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 1.04
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 1.02
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 1.01
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.0
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 0.96
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.94
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.91
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.91
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.91
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 0.91
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 0.91
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.89
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 0.87
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.86
Transcriptomic analysis of LSD1 0.85
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.85
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.85
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 0.84
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.84
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 0.82
Histone Demethylases KDM3A and KDM4C regulate mesenchymal stromal cell senescence and bone aging through condensin-mediated heterochromatin organization 0.79
Modulation of nonsense-mediated decay by rapamycin 0.79
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 0.79
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 0.79
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.78
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.76
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.76
Safety profiling of genetically engineered Pim-1 kinase overexpression for oncogenicity risk in human c-kit+ cardiac interstitial cells 0.75
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 0.71
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.69
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 0.65
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.64
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 0.6
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 0.6
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.6
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.59
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.59
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.58
Metastasis in triple-negative breast cancer 0.58
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.58
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.58
ML29755 RNA-seq data 0.55
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.54
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 0.53
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 0.53
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 0.5
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.48
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.46
Molecular analysis of renal cell carcinoma with unclassfied histology 0.45
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 0.45
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.44
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.42
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.41
RNA-Seq and expression data from human adipose tissue 0.41
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 0.4
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.38
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.37
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.37
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 0.36
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 0.36
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 0.35
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.33
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.32
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.32
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.3
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.3
HBEC-shp53-PCHD7 0.3
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.29
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.29
Identification of a LIF-responsive replication-competent human β cell 0.29
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.26
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.24
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 0.22
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 0.22
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.22
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.22
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.2
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.2
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.19
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.18
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.17
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.17
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 0.17
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 0.17
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 0.17
Dermal endothelial cells of type 2 diabetic patients 0.17
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 0.16
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 0.14
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 0.14
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  0.14
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.11
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.11
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.08
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.07
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 0.06
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 0.05
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 0.03
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.02
Epigenomic conservation of transposable element silencing [RNA-seq] 0.02
Epigenomic conservation of transposable element silencing 0.02
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 0.01
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.01
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation